| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.18 | 0.002 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.003 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.097 | 0.003 |